Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. [electronic resource] by
- Xu, Yan-Ping
- Lv, Lei
- Liu, Ying
- Smith, Matthew D
- Li, Wen-Cai
- Tan, Xian-Ming
- Cheng, Meng
- Li, Zhijun
- Bovino, Michael
- Aubé, Jeffrey
- Xiong, Yue
Producer: 20200615
In:
The Journal of clinical investigation vol. 129
Availability: No items available.
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
|
|
|
68.
|
|
|
|
69.
|
|
|
|
70.
|
|
|
|
71.
|
|
|
|
72.
|
|
|
|
73.
|
|
|
|
74.
|
|
|
|
75.
|
|
|
|
76.
|
|
|
|
77.
|
|
|
|
78.
|
|
|
|
79.
|
|
|
|
80.
|
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. [electronic resource] by
- Wang, David
- Quiros, Jason
- Mahuron, Kelly
- Pai, Chien-Chun
- Ranzani, Valeria
- Young, Arabella
- Silveria, Stephanie
- Harwin, Tory
- Abnousian, Arbi
- Pagani, Massimiliano
- Rosenblum, Michael D
- Van Gool, Frederic
- Fong, Lawrence
- Bluestone, Jeffrey A
- DuPage, Michel
Producer: 20191105
In:
Cell reports vol. 23
Availability: No items available.
|